Skip to main content

Intussusception Risk after Rotavirus Vaccination in U.S. Infants

Basic Details
Date
Type
Publication
Medical Product
Rotarix
RotaTeq
rotavirus vaccine
Health Outcome(s)
intussusception
Description

This article describes the findings of a study conducted to evaluate the risk of intussusception associated with two Rotavirus vaccines, Rotateq (RV5) and Rotarix (RV1), in infants 5 to 30.9 weeks of age in the United States. 

Materials

The New England Journal of Medicine, Volume 370. No 6, February 2014, Pages 503-512 DOI:10.1056/NEJMoa1303164

Information
Time Period
2004–2011
Population / Cohort
All infants 5 to 30.9 weeks of age
Data Source(s)
Mini-Sentinel Distributed Database (MSDD)
Related Assessment(s)
Intussusception Risk After Rotavirus Vaccination in U.S. Infants
Author(s)

W. Katherine Yih PhD, MPH, Tracy A. Lieu MD, MPH, Martin Kulldorff PhD, David Martin MD, MPH, Cheryl McMahill-Walraven PhD, MSW, Richard Platt MD, MSc, Nandini Selvam PhD, MPH, Mano Selvan PhD, Grace M. Lee MD, MPH, Michael Nguyen MD

Corresponding Author

W. K. Yih, Department of Population Medicine, Harvard Pilgrim Healthcare Institute and Harvard Medical School, 401 Park Drive, Suite 401 East, Boston, MA 02215, U.S.A. E-Mail: katherine_yih@harvardpilgrim.org